Literature DB >> 23868209

On the mechanism of degradation of oxytocin and its analogues in aqueous solution.

Kazimierz Wiśniewski1, Jens Finnman, Marion Flipo, Robert Galyean, Claudio D Schteingart.   

Abstract

Oxytocin (OT) is a cyclic nonapeptide containing one internal disulfide bond between its Cys(1) and Cys(6) residues. Although OT is one of the most commonly used peptidic drugs, the mechanism of its degradation in aqueous solution and the identity of its degradants have not been fully elucidated. To investigate the pathways and products of OT degradation in slightly acidic to neutral solutions, we prepared the peptides: OT, [D-Cys(1)]OT, a series of N-alkylated OT analogues, [[(13)C3,(15) N]Cys(1)]OT, and OT where each sulfur atom was systematically replaced by either methylene, (34)S, or Se. The peptides were incubated at 40°C and the degradation products studied by HPLC, LCMS, and (13)C-NMR. Our findings suggest that the degradation begins with β-elimination of the disulfide linkage to form a putative intermediate linear peptide containing an S-thiocysteine (a persulfide) in position 6 and a dehydroalanine in position 1. This intermediate persulfide appears to donate a sulfur atom to an intact OT molecule to form OT trisulfide and higher monomeric polysulfides, while the dehydroalanine residue is hydrolyzed with loss of the N-terminal amino group to yield a linear N-pyruvoylated octapeptide containing a reduced Cys(6). Based on the MS and (13)C-NMR data of the products from degradation of [[(13)C3,(15)N]Cys(1)]OT, we postulate that the ultimate degradation products of OT are dimers composed of two pyruvoylated octapeptides held together by one disulfide bridge between the two Cys(6) residues and by one more, non-reducible, linkage resulting from an aldol-type condensation between the two N-terminal pyruvoyl groups.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  OT analogues; mechanism of degradation; oxytocin; stability in solution; β-elimination

Mesh:

Substances:

Year:  2013        PMID: 23868209     DOI: 10.1002/bip.22260

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  5 in total

Review 1.  Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primer.

Authors:  Annette Bak; Dennis Leung; Stephanie E Barrett; Seth Forster; Ellen C Minnihan; Andrew W Leithead; James Cunningham; Nathalie Toussaint; Louis S Crocker
Journal:  AAPS J       Date:  2014-11-15       Impact factor: 4.009

2.  Development and stability of a heat-stable formulation of carbetocin for the prevention of postpartum haemorrhage for use in low and middle-income countries.

Authors:  Mattias Malm; Ingbritt Madsen; Johan Kjellström
Journal:  J Pept Sci       Date:  2018-04-27       Impact factor: 1.905

3.  Degradation of Multiple Peptides by Microcystin-Degrader Paucibacter toxinivorans (2C20).

Authors:  Allan A Santos; Sylvia Soldatou; Valeria Freitas de Magalhães; Sandra M F O Azevedo; Dolores Camacho-Muñoz; Linda A Lawton; Christine Edwards
Journal:  Toxins (Basel)       Date:  2021-04-08       Impact factor: 4.546

4.  Quality, availability and storage conditions of oxytocin and misoprostol in Malawi.

Authors:  Nhomsai Hagen; Felix Khuluza; Lutz Heide
Journal:  BMC Pregnancy Childbirth       Date:  2020-03-29       Impact factor: 3.007

5.  Stability of Oxytocin Preparations in Malawi and Rwanda: Stabilizing Effect of Chlorobutanol.

Authors:  Nhomsai Hagen; Thomas Bizimana; Pierre Claver Kayumba; Felix Khuluza; Lutz Heide
Journal:  Am J Trop Med Hyg       Date:  2020-11       Impact factor: 2.345

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.